The direction of these results was confirmed by two double-blind RCTs with placebo where BC was effective reducing severity of URTI affecting IgA deficient patients [51] and decreasing frequency and severity of both vomiting and diarrhea in infants with gastrointestinal infection diseases [49]. This evidence concerns the gene CD79A and breast cancer.